For patients with early-stage cervical cancer, sentinel lymph node biopsy alone is noninferior to lymphadenectomy with respect to disease-free survival, according to a study published online Oct. 15 ...

A genomic test co-developed by Mayo Clinic and SkylineDx can identify whether people with melanoma are at low or high risk ...

MONDAY, Oct. 27, 2025 (HealthDay News) — An already-available genetic test might spare some melanoma patients from a surgical ...

A recent prospective study sought to identify the subgroup of melanoma patients (based on age and tumor thickness) in which the risk of nodal metastasis is low and who may avoid routine SLN biopsy.

The sentinel lymph node (SLN) is the lymph node that represents the 'gate-keeper' of the lymphatic basin; it is the first node to receive lymphatic drainage from the site of the primary tumor. SLN ...

Early detection, advanced drug therapies, and less invasive surgeries are transforming breast cancer care, offering better ...

For many diseases, the ability to quickly and effectively diagnose or prognose a patient is critical. If caught early on, doctors and patients are given the time to properly analyze and treat the ...

Please provide your email address to receive an email when new articles are posted on . Up to 88% of sentinel lymph node biopsies (SNLB) return with a negative result. The DecisionDx-Melanoma test, ...

Among patients with T1a cutaneous melanomas, younger age and tumors in the head/neck region were most likely to demonstrate sentinel lymph node positivity, according to a study. “Sentinel lymph node ...

Older women with a very early, non-invasive breast cancer known as ductal carcinoma in situ (DCIS) gain no long-term benefit from undergoing a sentinel lymph node biopsy to see if the cancer has ...

One of the most important incremental steps in breast cancer has been to lessen the amount of axillary surgery that is needed to stage breast cancer. Sentinel node biopsy appears to lead a much lower ...

Lymph node status is one of the most important prognostic factors in cutaneous malignant melanoma. According to the 2002 American Joint committee on Cancer (AJCC) staging for cutaneous melanoma, the ...